Business Wire

GSMA Launches Mobile World Congress Shanghai 2018

Jaa

The GSMA today announced the first details of the 2018 GSMA Mobile World Congress Shanghai, including confirmed exhibitors and sponsors, as well as a range of programmes and activities taking place at the annual mobile industry event. Under the theme “Discover a Better Future”, Mobile World Congress Shanghai will be held 27 – 29 June 2018 at the Shanghai New International Expo Centre (SNIEC). The GSMA expects that more than 60,000 professionals from across the mobile ecosystem and adjacent industries will gather for the 2018 event.

“Today, mobile connects more than two-thirds of the world's population. It revolutionises industries and improves our lives, creating exciting new opportunities in our global communities, while providing lifelines of hope and reducing inequality,” said Michael O’Hara Chief Marketing Officer, GSMA. “Innovation is at the very heart of a better future for all and Mobile World Congress Shanghai will showcase the technologies, products and services that are fuelling this innovation.”

Mobile World Congress Shanghai to Showcase More Than 600 Companies

Covering seven halls at the SNIEC, the Mobile World Congress Shanghai exhibition will showcase the leading products, services and technologies that are shaping the future of mobile, from handsets and devices to network infrastructure, software and services and much more. Major event partners include China Mobile and Huawei; the two companies will also have a presence in the exhibition alongside more than 600 participating companies overall, including AAC Acoustic, AsiaInfo, BICS, China Transport Telecommunication and Information, Continental, Datang, Ericsson, Gemalto, Gionee, H3C Technologies, Hengtong Optic-Electric, HTC, Nokia, Qualcomm, RFS, Rohde & Schwarz, Samsung LSI, STMicroelectronics, Volkswagen and ZTE, among others.

A top destination at Mobile World Congress in Barcelona, NEXTech is making its way to Mobile World Congress Shanghai. Located in Hall W5 of the SNIEC, NEXTech puts the spotlight on next-generation technology, with focused exhibition areas showcasing companies and innovative technologies that are driving disruption across the entire mobile ecosystem. NEXTech will highlight cutting-edge technologies including VR and AR, robotics, connected and autonomous cars, and artificial intelligence. NEXTech will also feature 4 Years From Now (4YFN), with an exhibition showcasing over 100 local and international startups. The 4YFN programme will also encompass a series of startup collaboration and investor networking activities.

The GSMA Innovation City will again be a major highlight at Mobile World Congress Shanghai, enabling attendees to experience technology in context, illustrating how mobile-connected products and services can improve daily lives and transform industries in areas such as automotive, healthcare, smart homes, transport logistics and more.

The Youth Mobile Festival (YoMo) will return to Mobile World Congress Shanghai and once again provide an engaging, fun and hands-on educational experience for young people and families to experience the power of science, technology, engineering, arts/design and maths (STEAM) disciplines. For more information on the Mobile World Congress Shanghai exhibition, visit www.mwcshanghai.com/#exhibit.

Conference to Explore Latest Trends and Topics in Mobile

The 2018 Mobile World Congress Shanghai conference programme will be held 27 – 29 June in the SNIEC. In addition to four keynote sessions, the conference incorporates seven focused summits including the 5G Summit, the Artificial Intelligence (AI) Summit, the Future Vehicles Summit, the Marketing Excellence Summit, the Future Operator Summit, the Global Device Summit and the Internet of Things (IoT) Summit. New for 2018, Mobile World Congress Shanghai will feature the Leaders Stage, where industry leaders, heads of government and other thought leaders will offer their perspectives and insights on a wide range of topics including societal issues, economy and commerce, the world of work, and much more.

The Call for Papers for Mobile World Congress Shanghai is now open and prospective speakers can submit proposals through 23:59 Hong Kong time on Friday, 19 January 2018. To submit Call for Papers, visit www.mwcshanghai.com/become-a-speaker/.

Women4Tech Makes its Shanghai Debut

Following its highly successful launch at Mobile World Congress 2017, the Women4Tech programme is coming to Shanghai. Women4Tech is designed to address and reduce the gender gap in the mobile industry. A central element of the programme is the Women4Tech Summit, which will bring together senior-level speakers and panellists to discuss how to ensure gender equality in mainstream work environments, and share strategic advice on broadening gender diversity in mobile and related industries. The Summit will highlight topics around women’s role in empowering, encouraging, transforming and innovating in technology. Additional Women4Tech activities include a speed coaching and networking session, specialised tours, activities at 4YFN and Women4Tech Asia Mobile (AMO) Awards for Outstanding Achievement Asia Industry Leadership, among others.

Largest Carbon Neutral Exhibition and Conference in Asia

Mobile World Congress Shanghai has again been officially certified by the British Standards Institution as carbon neutral under the international PAS 2060 standard, reinforcing its position as the largest carbon neutral exhibition and conference in Asia. The GSMA implemented a range of measures to reduce emissions for Mobile World Congress Shanghai 2017, resulting in a greenhouse gas reduction of more than 104 tonnes of carbon dioxide equivalent. To compensate for the remaining carbon footprint, the GSMA is supporting United Nations-certified projects in China, including a waste gas for power generation project in Shaanxi, as well as a hydropower station project in Gansu. For more information, visit www.mwcshanghai.com/about-the-gsma/environmental-programme/.

Follow Developments at Mobile World Congress Shanghai 2018

For more information on the 2018 Mobile World Congress Shanghai, including how to attend, exhibit, partner or sponsor, visit www.mwcshanghai.com. Follow developments and updates on Mobile World Congress Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWCS18, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/company/mobile-world-congress-shanghai, and follow us on Facebook at www.facebook.com/mwcshanghai. In China, you can follow us on Sina Weibo http://weibo.com/mwcshanghai or search “GSMA_MWCS” in WeChat.

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

For the GSMA
Ava Lau, +852 2533 9928
alau@webershandwick.com
or
Cara Delaney, +44 20 7067 0190
Cara.Delaney@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

European Commission approves Ipsen’s Cabometyx® (cabozantinib) for the treatment of hepatocellular carcinoma in adults previously treated with sorafenib15.11.2018 09:30Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the European Commission (EC) has approved Cabometyx® (cabozantinib) 20, 40, 60 mg as a monotherapy for hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib. This approval allows for the marketing of Cabometyx® (cabozantinib) in this indication in all 28 member states of the European Union, Norway and Iceland. “Today’s EC approval for the use of Cabometyx ® provides a much needed new option for HCC patients. Until now, physicians in Europe had only one approved therapy for the 2 nd line treatment of this aggressive and difficult-to-treat cancer.1,2 We are proud to offer Cabometyx ® as an innovative treatment that has been shown to extend survival in previously treated patients with HCC,” said Harout Semerjian, Chief Commercial Officer, Ipsen. “This new indication reinforces Ipsen’s commitment to improve patients’ lives through the expansion of the clinical benefit of Cabometyx ® i

Mobidiag nostaa viimeisen €4M erän Euroopan investointipankin €15M rahoituksesta15.11.2018 09:30Tiedote

Mobidiag Oy, vahvassa kasvuvaiheessa oleva molekyylidiagnostiikkayhtiö, joka taistelee antibioottiresistenssin leviämistä vastaan, ilmoitti tänään, että se on nostanut viimeisen 4 miljoonan euron erän 15 miljoonan euron lainasta, jonka Euroopan investointipankki (EIP) myönsi yhtiölle kolmivuotiseen projektiin heinäkuussa 2016. Laina myönnettiin osana EIP:n ”InnovFin - EU Finance for innovators” -ohjelmaa. Ohjelman tavoitteena on tukea innovatiivisten eurooppalaisten yhtiöiden haastavia korkean teknologian kehityshankkeita mahdollistamalla rahoituksen. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20181114005789/fi/ Aiemmin nostettujen EIP:n lainaerien avulla Mobidiag on kehittänyt valmiiksi ja kaupallistanut Novodiag® -molekyylidiagnostiikan järjestelmänsä sekä kaksi suolistoinfektioiden aiheuttajien tunnistamiseen käytettävää testiä (Novodiag® C. difficile ja Novodiag® Bacterial GE+). Viimeisen lainaerän avulla yhtiö nope

Mobidiag Receives Final €4M Tranche of €15M EIB Financing15.11.2018 09:30Tiedote

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, announced today that it has received the final €4M tranche of a €15M three-year project secured by the Company from the European Investment Bank Group (EIB) in July 2016. The loan was provided as part of “InnovFin – EU Finance for innovators” programme, an EIB initiative aimed at providing innovative and high quality companies in Europe with access to finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005786/en/ The EIB funding has already enabled Mobidiag to finalize, launch and commercialize its Novodiag® molecular diagnostic system and two assays for detection of gastrointestinal infections (Novodiag® C. difficile and Novodiag® Bacterial GE+). The final tranche will enable the Company to continue growing its product portfolio, accelerate the development of further assays for the Novodiag® system an

Highlights of China’s No. 1 High-Tech Fair CHTF 201815.11.2018 05:00Tiedote

The 20th China Hi-Tech Fair (CHTF 2018) is being held from November 14-18 at the Shenzhen Convention and Exhibition Center with the theme “New Development Concept for High Quality Growth.” This year’s CHTF consists of exhibitions, forums, professional meetings, supporting activities, talents exchange meetings and overseas fairs, and features advanced manufacturing, next-generation information technology, AI, life sciences, new materials, new energy, as well as integration of real economy and future industries. Here are some of the highlights of CHTF 2018: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005654/en/ International and Belt & Road Pavilion of CHTF (Photo: Business Wire) Themed areas focusing on industry hotspots The IT exhibition will present themed areas like AI, smart manufacturing, smart automotive, sports technology, big data, cloud computing, IoT and blockchain; the environmental exhibition will highlig

MapleStory Prepares for Epic Battle Against the Black Mage in Gathering of Heroes Event15.11.2018 00:00Tiedote

MapleStory, the iconic global MMORPG from Nexon America, is bringing the first phase of its long-awaited battle with the sinister villain, the Black Mage. Between November 14 through November 28, players can take part in the “Gathering of Heroes” event to join the Maple Alliance and prepare their armies to soon combat the Black Mage. The Black Mage has long been the main antagonist behind MapleStory. His story originated with the role of bringing balance to Maple World, but turned dark as he realized the only way to save Maple World was to destroy it. Now that his seal has been broken, players will need to work together to defeat the legendary boss. The Gathering of Heroes event adds the Maple Alliance outpost, where players can hone their skills and prepare to level up in preparation of for their battle against the Black Mage, as well as adds various leveling updates. The main goal of the Alliance is to gather “Determination” and power up the holy light in the outpost to be able to fi

SpinalCyte Announces Sustained 12-Month MRI Outcomes After CybroCell™ Injection14.11.2018 23:07Tiedote

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced that a single injection of modified human dermal fibroblasts (HDFs), resulted in significant improvements of disc height and pain reduction 12 months after injection of the cell therapy for patients with degenerative disc disease (DDD). The trial assessed patients using the Oswestry Disability Index (ODI), Visual Analogue Scale (VAS) and disc height via MRI scans. Using composite scoring, 54% of the treatment arm patients met all three endpoints as compared to only 17% with the placebo (p=0.0003). Over 84% of patients in the treatment group of CybroCell™ or CybroCell™ with platelet rich plasma (PRP) injections had an increase or no change in disc height compared to 25% for the placebo saline injection. Analyzed individually, 83% of spinal discs that were injected with CybroCell™ had an increase or no change in disc he

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme